Investors

Investor Relations

Regenerex Pharma, Inc. (Symbol: RGPX) is focused on bringing next generation wound care solutions to market. Our mission is to ensure the next major medical milestone in healthcare, by enabling healing to the vast majority of chronic wounds once thought untreatable. In an age of growing diabetic populations and rising healthcare costs, our products demonstrate new possibilities in wound closure systems and introduce economic models with greater predictability and cost savings for payers. The solutions Regenerex Pharma is bringing to the healthcare market are targeted at advancing healing, patient care, and payer models at scale in the United States and abroad.

Headquarters

5348 Vegas Drive, Suite 177
Las Vegas, NV 89108
Phone: 1-877-761-RGPX (7479)

Investor Relations line

Phone: 1-305-927-5191
investors@regenerexpharmainc.com

Transfer agent

Transfer Online, Inc.
512 SE Salmon St.
Portland, OR 97214
Phone: 1-503-227-2950
transferonline.com
Cusip: 713468106

Auditors

Michael L. McKennon
dbbmckennon
Certified Public Accountants
Registered Firm – PCAOB
20321 SW Birch Street, Suite 200
Newport Beach, California 92660

Safe Harbor & Disclaimer

The information provided on this website, other than historical information, may include forward-looking statements and involve factors, risks, and uncertainties that may cause actual results in future periods to differ materially from such statements. These factors, risks, and uncertainties include market acceptance and availability of new products and services, in addition to: the nonexclusive and terminable-at-will nature of reseller agreements with manufacturers; rapid technological change affecting products and services; the impact of competitive products and services, as well as competition from other resellers and service providers; possible delays in the launch of new products; and the availability of sufficient financial resources to enable the Company to expand its operations and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission (SEC). Regenerex Pharma, Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are urged to see Regenerex Pharma, Inc. filings with the SEC for current information concerning the Company.

Reach Out

If you have questions, please contact us.